Omegaven Expanded Access Protocol
Protocol for Patients With Parenteral Nutrition Associated Liver Disease (PNALD) to Access Parenteral Fish Oil (Omegaven®) - Omegaven IND 122375
Sponsor: St. Luke's Health System, Boise, Idaho
A observational or N/A phase clinical study on Parenteral Nutrition Associated Liver Disease, this trial is ongoing. The trial is conducted by St. Luke's Health System, Boise, Idaho and has accumulated 9 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Sep 2020 — Jan 2021 [monthly]
No Longer Available
-
May 2019 — Sep 2020 [monthly]
No Longer Available
Status: Available → No Longer Available
▶ Show 4 earlier versions
-
Jun 2018 — May 2019 [monthly]
Available
-
Apr 2018 — Jun 2018 [monthly]
Available
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Available NA
-
Jan 2017 — Feb 2017 [monthly]
Available NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- St. Luke's Health System, Boise, Idaho
For direct contact, visit the study record on ClinicalTrials.gov .